Clinical trials in Bamberg – page 4

55 clinical trials in Bamberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in GermanyKlinischeStudien.de

Bamberg at a glance

clinical trials

Not yet recruiting0
Paediatric trials0
Research sites0

Quick filters

55 trials in Bamberg

Open in trial search

Breast cancer+7

Not recruiting

Study of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Study of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:GBG Forschungs GmbH

Contact Research Centre

Idiopathic pulmonary fibrosis+1

Not recruiting

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Investigational

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:BI 1839100
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Interstitial lung disease

Not recruiting

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational

Germany

Participants:65+ years
Substances:BI 1015550
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting

Registered drugNo placebo

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bleomycin Sulfate
Sponsor:University Of Cologne

Contact Research Centre

Colitis ulcerative

Not recruiting

Study on the Effects of Fecal Microbiome and Fecal Microbiome Filtrate Capsules for Patients with Active Ulcerative Colitis

Registered drug

Study on the Effects of Fecal Microbiome and Fecal Microbiome Filtrate Capsules for Patients with Active Ulcerative Colitis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Metronidazole
Sponsor:Friedrich-Schiller-Universitaet Jena

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Registered drug

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Budesonide
Sponsor:AstraZeneca AB

Contact Research Centre

Eosinophilic granulomatosis with polyangiitis

Not recruiting

Study on Benralizumab and Mepolizumab for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) Receiving Standard Care

Registered drug

Study on Benralizumab and Mepolizumab for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) Receiving Standard Care

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Benralizumab
Sponsor:AstraZeneca AB

Contact Research Centre

Follicle centre lymphoma follicular grade I II - III refractory

Not recruiting

Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo

Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Epcoritamab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:BI 1015550
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Follicular lymphoma

Not recruiting

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Registered drugNo placebo

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:LYSARC

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Registered drug

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Acalabrutinib
Sponsor:Acerta Pharma B.V.

Contact Research Centre

Hypercholesterolaemia

Not recruiting

Study Comparing Inclisiran and Bempedoic Acid for Lowering LDL Cholesterol in Patients with Atherosclerotic Cardiovascular Disease

Registered drugNo placebo

Study Comparing Inclisiran and Bempedoic Acid for Lowering LDL Cholesterol in Patients with Atherosclerotic Cardiovascular Disease

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atorvastatin
Sponsor:Novartis Pharma GmbH

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 518 cities in Germany

Clinical research in Bamberg

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure prevention and management of cardiovascular disease, investigating new therapeutic combinations and treatments for improving patient outcomes.

Heart Failure Prevention
Cardiovascular Disease Management
Cholesterol Control

Multiple trials evaluating novel approaches to reduce major cardiovascular events and improve lipid management.

02 Respiratory Medicine

Comprehensive research into chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis, exploring new treatment options and therapeutic combinations.

COPD Management
Pulmonary Fibrosis
Severe Asthma

Trials focusing on improving lung function and reducing disease progression in chronic respiratory conditions.

03 Oncology Studies

Advanced research in multiple myeloma and various types of lymphoma, including studies on breast cancer treatments and innovative therapeutic approaches.

Multiple Myeloma
Lymphoma Treatment
Breast Cancer Therapy

Investigating breakthrough treatments for various types of cancer, with emphasis on targeted therapies.

04 Gastrointestinal Research

Studies examining treatments for celiac disease, ulcerative colitis, and other digestive disorders, focusing on innovative therapeutic approaches.

Celiac Disease Management
Ulcerative Colitis Treatment
IBS Research

Evaluating new therapeutic options for chronic gastrointestinal conditions.

Back to Germany All countries